Craft

Flexion Therapeutics

Revenue

$85.6 M

FY, 2020

Flexion Therapeutics Summary

Company Summary

Overview
Flexion Therapeutics is a biotechnology company that develops long-lasting intra-articular injection therapies to treat osteoarthritis. It is focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis, a type of degenerative arthritis.
Type
Subsidiary
Status
Active
Founded
2007
HQ
Burlington, MA, US | view all locations
Website
http://flexiontherapeutics.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Scott A. Canute
  • Michael D. Clayman

    Michael D. Clayman, Chief Executive Officer, Co-Founder and Director

    • Melissa Layman

      Melissa Layman, Chief Commercial Officer

    • Frederick Driscoll

      Frederick Driscoll, Chief Financial Officer

    LocationsView all

    1 location detected

    • Burlington, MA HQ

      United States

      10 Burlington Mall Road #301

    Flexion Therapeutics Financials

    Summary Financials

    Revenue (Q3, 2021)
    $21.3M
    Gross profit (Q3, 2021)
    $17.6M
    Net income (Q3, 2021)
    ($30.3M)
    EBIT (Q3, 2021)
    ($24.2M)

    Footer menu